Clincosm LogoSign in Get a demo

Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer

Sponsor
Stanford University (Other)
Overall Status
Recruiting
CT.gov ID
NCT00230308
Collaborator
(none)
500
Enrollment
1
Location
344
Anticipated Duration (Months)
1.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Through this study, we hope to learn more about the mechanisms, which may contribute to development and progression of head and neck cancer. The long-term goal of this study will be to develop new strategies and drugs for the diagnosis and treatment of head and neck cancer.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    500 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
    Actual Study Start Date :
    Apr 2, 2002
    Anticipated Primary Completion Date :
    Jun 1, 2030
    Anticipated Study Completion Date :
    Dec 1, 2030

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:

      All patients undergoing surgery at Stanford University for head and neck cancer.

      Exclusion Criteria:

      Non-Stanford patients.

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Stanford University School of Medicine Stanford California United States 94305

      Sponsors and Collaborators

      • Stanford University

      Investigators

      • Principal Investigator: John B Sunwoo, Stanford University

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      Stanford University
      ClinicalTrials.gov Identifier:
      NCT00230308
      Other Study ID Numbers:
      • IRB-11402
      • 76537
      • ENT0008
      • 11402
      First Posted:
      Sep 30, 2005
      Last Update Posted:
      Aug 4, 2021
      Last Verified:
      Aug 1, 2021
      Keywords provided by Stanford University
      Head and Neck Cancer
      Additional relevant MeSH terms:
      Head and Neck Neoplasms

      Study Results

      No Results Posted as of Aug 4, 2021